After introductory remarks, the Workshop presenter will examine the weaknesses and strengths of the Conventional and Integrative oncology systems. Thereafter, we will compare the strengths and weaknesses of Holistic Oncology, focusing on the Institute’s anti-cancer mini-protocols. Hereinafter, the topics that will be covered. This workshop will be presented via powerpoint.
« L’urgence en cancérologie, ce n’est pas d’opérer, mais c’est de traiter les micro métastases. » Prof. POUYARD Institut Curie (“The urgency in oncology is not to use surgery, but to address micro-metastases”)
1. Evaluating the molecular biology of the tumor cell population and, in particular, its CTC and CSC spreads. (CTC – Circulating tumor cells & CSC – cancer stem cells) as well as other tests. We will look at some of the best labs where the patient-student can order most tests directly. We will also delve into exegesis, or how to interpret a few of these cancer tests and what to aim for. Reviewing efficient and safe monitoring techniques to make sure the chosen options are consistent with evidenced-based progress in cancer control and reversal.
2. Carcinogenesis and the major Cancer Hallmarks: Is cancer a genetic, epigenetic, infectious, immune, neurological or metabolic disease ? (1)
3. Examining the conventional and holistic cancer diagnosis.
4. Studying the strengths and limitations of conventional allopathic oncology. (2) Case studies.
5. Strengths and weakness of integrative oncology. Case studies.
6. Introduction to Holistic Oncology: Definition and general principles. On the issues of Evidence, standards of care and Randomized Clinical Trials. (3) Case studies.
7. Holistic Detoxification (metabolic and exogenous).
8. Chosing an adapted diet that corresponds to the patient’s health challenges, terrain and genetic constitution. Ph regulation. Stress management, heat therapy and exercises. Dealing with the glycolysis and specific anti-cancer clinical nutrition, spices and herbs.
9. Turning off the pathways that govern excessive free radicals and growth factors which promote cancer development.
10. De-activating malignant angiogenesis.
11. Quieting the malignancy-based inflammation cascade.
13. Correcting coagulation.
14. Immune-building, immune-modulation, re-activation of the innate immunity and the dendritic surveillance system.
15. Addressing key genes (downregulating oncogenes and upregulating tumor suppressor genes).
16. Dealing with cancer stem cells, the inhibition of micro-metastases and metastasis pathways.
17. Reviewing other anti-mitotic, metabolic and anti-cancer proliferation holistic techniques, from hyperthermia to electric regulation, acupuncture and electro-acupuncture, to oxygenation improvement, cellular homeostasis, atp normalization and selective malignant cyto-toxic natural substances that induce apoptosis and malignancy necrosis, among other activations.
18. Exploring fasting techniques: From alternate fasting, to intermittent fasting, water fasts, juice fasts and the fasting mimicking diet. Exploring autophagy, circadian rhythms, Telomeres, hormonal and stem cell regeneration.
19. Essential Oils, lymphatic massage, EFT, Meditation techniques, sleep, exercises and other anti-stress techniques.
20. Maintaining bone integrity, managing cancer pain and oxygen therapies: from the HBOT (hyperbaric oxygen chamber), to the floating chamber, to the altitude chamber, to aromatherapy, the Bol de Jacquier technique, breathing exercises and more.
21. Repairing and-or correcting allopathic oncology’s damages (when possible, from cancer wounds that don’t heal well, to traumatizing surgeries, to radiation fibrosis, to chemo brain fog, to immune and gut destruction and allopathic cancer stem cell activation).
22. Nurturing emotional wellbeing and spiritual health.
23. Dentistry and energy medicine.
24. Addressing cancer via the cellular senescence and longevity pathways.
24. Addressing cachexia, anorexia, pain and social-family issues.
25. Medical law: Rights of patients, duties of doctors and obligations of public entities that deal with public health.
“The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA”. Cf. Morgan G1, Ward R, Barton, The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. M. Clin Oncol (R Coll Radiol). 2004 Dec;16(8):549-60. (Source
(1). For M.I.T.’s Professor Weinberg and most of the other recognized mainstrain allopathic oncologists, cancer is a genetic disease with six inter-related cell physiology alterations: 1) autonomy in growth signals, 2) insensitivity to growth inhibitory (antigrowth) signals (e.g. tumor suppressor genes), 3) evasion of programmed cell death (apoptosis), 4) limitless replicative potential as long as there’s glucose in the micro-environment, 5) sustained vascularity (angiogenesis), and 6) tissue invasion and metastasis. (Source) . While we do not refute the importance of these above-mentioned elements, the Advanced Cancer Research Institute’s fundamental research work has determined that these above mentioned cancer hallmarks are “epi-phenomema”, meaning not central to the cancer process, if only because it has been shown that a damaged mitochondria prevails over an altered nucleus insofar as malignancy is concerned. (Source) In order to benefit from cancer reversal, the health recipient must activate a treatment plan based on a correct analysis of carcinogenesis. This is the starting point to any and all safe and efficient cancer control and reversal processes.
(2). To whet the student’s appetite, a few facts: For most of the common solid cancers, mainstream conventional cancer treatments based on cyto-toxic chemo-therapy bestow upon cancer patients less than 3 percent “five years” survivability success rate. (See quote above) Not only can chemotherapy worsen the tumor’s micro-environment, it can also make the engins of metastases, the cancer circulating stem cells, mutate and spread even more. Radiation has a similar effects. (Source) Likewise with many biopsies and surgeries, they too can significantly contribute to the spreading of the malignancy, via the cellular adhesion, immune suppression, surgical stress and inflammatory pathways. And to make matters worse, many conventional diagnoses and prognoses have built-in and often fatal flaws.
(3). Given the costs of Randomized Clinical Trials (hundreds of millions to billions of dollars), human RCT can’t exist in holistic oncology, if only because most of holistic oncology is lifestyle medicine and this type of medicine is not patentable, nor can it be squeezed into a double blind RCT, if only because the patient is aware of the holistic technique in question. On the other hand, there are prospective, epidemiological, observational and interventional studies that confirm holistic and integrative oncology’s clinical superiority over conventional oncololgy, some of we will review in this workshop.
2016 (c). Advanced Cancer Research Institute and agents. All rights reserved